Calogera M. Simonaro
Department of Genetics and Genomic Sciences
Mount Sinai School of Medicine
New York
NY 10029
USA
Name/email consistency: high
- Involvement of the Toll-like receptor 4 pathway and use of TNF-alpha antagonists for treatment of the mucopolysaccharidoses. Simonaro, C.M., Ge, Y., Eliyahu, E., He, X., Jepsen, K.J., Schuchman, E.H. Proc. Natl. Acad. Sci. U.S.A. (2010)
- Mechanism of glycosaminoglycan-mediated bone and joint disease: implications for the mucopolysaccharidoses and other connective tissue diseases. Simonaro, C.M., D'Angelo, M., He, X., Eliyahu, E., Shtraizent, N., Haskins, M.E., Schuchman, E.H. Am. J. Pathol. (2008)
- Joint and bone disease in mucopolysaccharidoses VI and VII: identification of new therapeutic targets and biomarkers using animal models. Simonaro, C.M., D'Angelo, M., Haskins, M.E., Schuchman, E.H. Pediatr. Res. (2005)
- Articular chondrocytes from animals with a dermatan sulfate storage disease undergo a high rate of apoptosis and release nitric oxide and inflammatory cytokines: a possible mechanism underlying degenerative joint disease in the mucopolysaccharidoses. Simonaro, C.M., Haskins, M.E., Schuchman, E.H. Lab. Invest. (2001)